NURIX THERAPEUTICS INC (NRIX) Institutional Ownership

NRIX is currently held by 2 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $28.51M based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026.

The largest disclosed holder is ARK Invest, which reported ownership valued at approximately $26.68M in its March 31, 2026 13F filing. Based on current market prices and the latest disclosed share count, ARK Invest's NRIX position is now estimated to be worth approximately $29.47M, representing an estimated gain of +10.45% since the filing period.

Major shareholders tracked on this page include ARK Invest, Renaissance Technologies LLC, and other prominent asset managers. Collectively, these investors account for approximately 100% of the total disclosed value among the investors covered in this analysis.

This page tracks institutional holding trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance to help investors analyze smart money sentiment toward NURIX THERAPEUTICS INC (NRIX).

Institutional Ownership Trend

Portfolio quarterInstitutional holdersTotal reported valueTotal shares
Q1 20262$28,506,5961,839,135
Q4 20251$30,400,1711,602,539
Q3 20252$15,663,6851,695,204
Q2 20252$18,189,0521,596,932
Q1 20252$19,606,8711,650,410
Q4 20241$28,830,7141,530,293
Q3 20242$55,338,3322,462,765
Q2 20242$55,249,8182,647,332
Q1 20242$38,742,1092,814,638
Q4 20232$32,973,5773,310,199
Q3 20232$20,381,5602,619,847
Q2 20231$22,588,0992,261,071